An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)
Condition(s):PresbyopiaLast Updated:November 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):PresbyopiaLast Updated:November 28, 2023Completed
Condition(s):PresbyopiaLast Updated:November 28, 2023Completed
Condition(s):Oncology [See Also, Affected System]Last Updated:August 20, 2015Unknown status
Condition(s):CataractLast Updated:August 5, 2022Not yet recruiting
Condition(s):Macular Edema Due to Diabetes Mellitus; Vitreous HemorrhageLast Updated:February 6, 2023Recruiting
Condition(s):Atopic Dermatitis; Atopic Asthma; Immunologic Activity AlterationLast Updated:April 5, 2023Recruiting
Condition(s):Dental Restoration Failure of Marginal Integrity; Dental CariesLast Updated:November 16, 2020Enrolling by invitation
Condition(s):HemianopsiaLast Updated:December 13, 2019Terminated
Condition(s):Retinitis PigmentosaLast Updated:June 9, 2011Completed
Condition(s):Non-arteritic Anterior Ischemic Optic Neuropathy (NAION); Trauma; Multiple Sclerosis (MS)Last Updated:January 18, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.